<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.1026938</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Machine learning-based metabolism-related genes signature and immune infiltration landscape in diabetic nephropathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Huangjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1973921"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Jinguo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2024482"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Junfeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1783486"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Qinglin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/599305"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fang</surname>
<given-names>Luo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1371745"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmacy, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jurong Yang, The Third Affiliated Hospital of Chongqing Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Xiaosong Qin, China Medical University, China; Kun Ling Ma, Zhejiang University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Qinglin Li, <email xlink:href="mailto:qinglin200886@126.com">qinglin200886@126.com</email>; Luo Fang, <email xlink:href="mailto:fangluo@zjcc.org.cn">fangluo@zjcc.org.cn</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Diabetes: Molecular Mechanisms, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1026938</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>08</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Zhang, Hu, Zhu, Li and Fang</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhang, Hu, Zhu, Li and Fang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>To identify the diagnostic biomarkers of metabolism-related genes (MRGs), and investigate the association of the MRGs and immune infiltration landscape in diabetic nephropathy (DN).</p>
</sec>
<sec>
<title>Methods</title>
<p>The transcriptome matrix was downloaded from the GEO database. R package &#x201c;limma&#x201d; was utilized to identify the differential expressed MRGs (DE-MRGs) of HC and DN samples. Genetic Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses of DE-MRGs were performed using &#x201c;clusterProfiler&#x201d; R package. WGCNA, LASSO, SVM-RFE, and RFE algorithms were employed to select the diagnostic feature biomarkers for DN. The ROC curve was used to evaluate discriminatory ability for diagnostic feature biomarkers. CIBERSORT algorithm was performed to investigate the fraction of the 22-types immune cells in HC and DN group. The correlation of diagnostic feature biomarkers and immune cells were performed <italic>via</italic> Spearman-rank correlation algorithm.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 449 DE-MRGs were identified in this study. GO and KEGG pathway enrichment analysis indicated that the DE-MRGs were mainly enriched in small molecules catabolic process, purine metabolism, and carbon metabolism. <italic>ADI1</italic>, <italic>PTGS2</italic>, <italic>DGKH</italic>, and <italic>POLR2B</italic> were identified as diagnostic feature biomarkers for DN <italic>via</italic> WGCNA, LASSO, SVM-RFE, and RFE algorithms. The result of CIBERSORT algorithm illustrated a remarkable difference of immune cells in HC and DN group, and the diagnostic feature biomarkers were closely associated with immune cells.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>
<italic>ADI1</italic>, <italic>PTGS2</italic>, <italic>DGKH</italic>, and <italic>POLR2B</italic> were identified as diagnostic feature biomarkers for DN, and associated with the immune infiltration landscape, providing a novel perspective for the future research and clinical management for DN.</p>
</sec>
</abstract>
<kwd-group>
<kwd>diabetic nephropathy</kwd>
<kwd>metabolism-related genes</kwd>
<kwd>immune infiltration landscape</kwd>
<kwd>diagnostic biomarker</kwd>
<kwd>machine learning</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="37"/>
<page-count count="11"/>
<word-count count="3957"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Diabetic nephropathy (DN) is one of the most common and serious complications of diabetes mellitus (DM). With the increase of incidence, DN has become one of the most important mortality factors in diabetic patients (<xref ref-type="bibr" rid="B1">1</xref>). In the United States, over 50,000 patients with diabetes were treated for end-stage renal disease (ESRD) (<xref ref-type="bibr" rid="B2">2</xref>). In China, the incidence and prevalence of DN have also increased dramatically over the past decades. Statistics in 2016 showed that the number of patients with diabetes combined with chronic kidney disease (CKD) in China is estimated to reach 24.3 million (<xref ref-type="bibr" rid="B3">3</xref>). In general, the prevalence of DN is expected to increase over the next few decades, especially in developing countries, as the prevalence of diabetes increases rapidly worldwide (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Concerning medical and health care expenditure has become a huge social and economic burden to society, there is an urgent need to improve the understanding of the mechanism of DN.</p>
<p>The pathogenesis of DN development and progression is complex and multifactorial, involving many pathways and mediators. Among them, metabolic disorders have received increasing attention. In addition to obvious glucose metabolism disorders, renal lipid homeostasis has received increasing attention in recent years (<xref ref-type="bibr" rid="B6">6</xref>). Unsatisfactory glycemic management and renal lipotoxicity were identified as one of the major factors in the progression of DN (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>). Lipotoxicity is mainly associated with dysfunctional signaling and insulin resistance in non-adipose tissues such as myocardium, pancreas, skeletal muscle, liver and kidney (<xref ref-type="bibr" rid="B9">9</xref>). Abnormal serum lipids and ectopic renal lipid accumulation are associated with the development of renal diseases, especially diabetic nephropathy. Excessive lipid accumulation alters cellular homeostasis and activates lipogenic and glycogengenic cellular signaling pathways. The quantity and quality of lipids are involved in renal injury associated with lipotoxicity by activating inflammation, oxidative stress, mitochondrial dysfunction, and cell death (<xref ref-type="bibr" rid="B10">10</xref>). Anti-lipopathic agents such as statins and PPAR agonists have initially demonstrated a role in renal protection and in reducing renal lipid accumulation (<xref ref-type="bibr" rid="B6">6</xref>). Given the important influence of lipid metabolism on DN, coupled with the fact that protein burden can significantly influence DN progression (<xref ref-type="bibr" rid="B11">11</xref>), and the obvious important influence of abnormal glucose metabolism, further study of metabolism may be the key to future DN treatment.</p>
<p>At present, through the application of bioinformatics and genome sequencing technology, biomarkers of disease can be better identified. In this study, a variety of bioinformatics algorithms were used to investigate the role of MRGs in the pathogenesis of DN, and four MRGs were identified as diagnostic feature biomarkers of DN. In addition, the correlation between immune cells and diagnostic biomarkers was preliminarily discussed. In conclusion, the results of this study will provide new perspectives and insights for the treatment of DN patients in the future.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Date collection</title>
<p>The transcriptome matrix was downloaded from the Gene Expression Omnibus (GEO) database (<uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</uri>). In this study, GSE96804 and GSE30122 were downloaded from the GEO database, and the batch effect of the transcriptome matrix was removed <italic>via</italic> &#x201c;SVA&#x201d; R package. The GSE96804 contains 20 human glomeruli control samples (unaffected portion of tumor nephrectomies) and 41 human glomeruli DN samples ([HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version]). The GSE30122 contains 26 glomerulus of control kidney samples, and 9 glomeruli of DN samples ([HG-U133A_2] Affymetrix Human Genome U133A 2.0 Array). Perl scripts were conducted to extract the gene expression matrix and the probes were annotated based on the platform annotation file.</p>
</sec>
<sec id="s2_2">
<title>Identification of metabolism-related genes and differential expression analysis</title>
<p>The metabolism-related genes (MRGs) were obtained from the Molecular Signatures Database (MSigDB) (<uri xlink:href="http://software.broadinstitute.org/gsea/msigdb">http://software.broadinstitute.org/gsea/msigdb</uri>). &#x201c;C2.cp.kegg. v7.5.1.symbols.gmt&#x201d; was used as the reference genes set and a total of 739 unique MRGs were extracted from the gene matrix using the Perl scripts. &#x201c;limma&#x201d; R package was conducted to identify the differential expression MRGs (DE-MRGs) in HC and RA group, and the threshold was set at |Fold Change| &#x2265; 1 and <italic>P</italic>-value &lt; 0.05.</p>
</sec>
<sec id="s2_3">
<title>Weighted gene co-expression network analysis</title>
<p>The WGCNA package was used for weighted gene co-expression network analysis (WGCNA) in R software. Firstly, DE-MRGs with variances greater than all quartile variances were selected to perform WGCNA analysis, because the results of network module analysis are easily affected by outlier samples, it was particularly important to remove outliers before constructing the network. In this study, the inter-array correlation (IAC) between chips was used to evaluate the distribution of microarray data and outliers with significantly lower mean IAC values will be removed. The co-expression network of genes conforms to no scale distribution, in another word, it follows a power law distribution. WGCNA selected the weighted coefficients to obtain the results that most accord with the scale-free network distribution. Finally, genes and gene modules were associated with clinical information to identify key genes with potential biological significance in the network. For any genes, gene significance (GS) relative to a certain dependent variable was defined as the correlation coefficient between its expression level and the level of the dependent variable. Pearson correlation coefficient was used for continuous dependent variables. For a Module, the definition of Module Significance (MS) relative to a certain dependent variable is the correlation coefficient between its characteristic gene and the level of the dependent variable. For any gene in a module, the module membership (MM) of this gene in the module is defined as the correlation coefficient between this gene and the characteristic gene of this module.</p>
</sec>
<sec id="s2_4">
<title>Diagnostic feature biomarkers screening of DE-MRGs</title>
<p>Multiple machine learning algorithms were utilized to identify the diagnostic feature biomarkers. The least absolute shrinkage and selection operator (LASSO) was a regression analysis algorithm and this algorithm obtained a refined model by constructing a penalty function: by finally determining that the coefficients of some indicators are zero, the LASSO algorithm achieves the purpose of reducing the set of indicators. Support vector machine (SVM) was a common discrimination method usually used for pattern recognition, classification and regression analysis. Moreover, it also was a supervised learning model in the field off machine learning. To avoid overfitting and achieve reliable accuracy, recursive feature elimination (RFE) algorithm was used to select the optimal genes from the training cohort. Therefore, SVM-RFE was performed to select the appropriate feature biomarkers. Finally, the overlapping genes of WGCNA, LASSO, RFE, and SVM-RFE was considered as diagnostic feature biomarker and the expression levels of candidate genes were further validated in the validation cohort.</p>
</sec>
<sec id="s2_5">
<title>Functional enrichment analysis</title>
<p>Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to identify potential functional components and pathways using &#x201c;clusterProfiler&#x201d; R packages (<xref ref-type="bibr" rid="B12">12</xref>). Gene Set Enrichment Analysis (GSEA) was utilized to enrich the KEGG terms in the HC and DN group, with <italic>P</italic> &lt; 0.05 was considered as statistically significant.</p>
</sec>
<sec id="s2_6">
<title>Immune infiltration landscape analysis</title>
<p>&#x201c;CIBERSORT&#x201d; R package was performed to investigate the immune infiltration landscape of HC and DN samples. The gene expression of immune cells based on &#x201c;CIBERSORT R script v1.03&#x201d; and the algorithm was run using the LM22 signature for 1000 permutations. Correlation analysis was performed to determine the relationships between immune cells <italic>via</italic> &#x201c;Corrplot&#x201d; R package and &#x201c;ggplot2&#x201d; R packages was utilized to determine the difference of immune cell between HC and DN samples.</p>
</sec>
<sec id="s2_7">
<title>Correlation analysis between diagnostic feature biomarkers and immune infiltrating cells</title>
<p>The correlation of the 4 diagnostic feature biomarkers and immune cells were estimated <italic>via</italic> Spearman&#x2019;s rank correlation algorithm. The correlation results were visualized in lollipop diagram <italic>via</italic> &#x201c;ggplot2&#x201d; R packages, and <italic>P</italic>-value &lt; 0.05 were considered as statistically significant.</p>
</sec>
<sec id="s2_8">
<title>Statistical analysis</title>
<p>All statistical analyses were performed using R software (version 4.1.0) and Perl scripts. Correlation analyses between the two variables were performed using the Spearman&#x2019;s rank correlation algorithm and <italic>P</italic>-value &lt; 0.05 was considered significantly different. Differential functions were analyzed using the Wilcoxon rank-sum test between the two groups, and statistical significance was set at <italic>P</italic>-value &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Identification of differential expressed of metabolism-related genes in DN</title>
<p>The workflow of this study was illustrated in the <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. A total of 20 HC samples and 41 DN samples were extracted from the GEO database (GSE30122, GSE96804). Under the threshold set at |Fold change| &#x2265; 1 and <italic>P</italic>-value &lt; 0.05, a total of 314 down-regulated and 135 up-regulated DE-MRGs were identified (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Heatmap diagram displayed the top 30 up-regulated and down-regulated DE-MRGs in HC and DN group (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). The principal component analysis (PCA) showed a clear separation between the HC and DN group based on the MRGs (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Study flow diagram.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Identification of DE-MRGs. <bold>(A)</bold> Volcano diagram shows the DEGs in HC and DN group. The threshold for screening the DEGs is set at |Fold Change| &#x2265; 1 and <italic>P</italic> -value &lt; 0.05. <bold>(B)</bold> Heatmap shows the top 30 up-regulated and down-regulated DE-MRGs in HC and DN group. <bold>(C)</bold> Principal component analysis illustrates a significant difference between the HC and DN samples based on the MRGs.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Functional enrichment analysis</title>
<p>To investigate the potential molecular mechanism of the DE-MRGs, the functional enrichment analysis was conducted. Biological process (BP) enrichment analysis showed that the DE-MRGs were significantly enriched in small molecule catabolic process, ribose phosphate metabolic process, and organic acid catabolic process (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). Kyoto Encyclopedia of Genes and Genome (KEGG) enrichment analysis suggested that carbon metabolism, purine metabolism, and glycolysis/gluconeogenesis were enriched of the DE-MRGs (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). GSEA results illustrated the top 5 KEGG signaling pathways in the HC and DN group. As shown in the <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>, the calcium signaling pathway, GNRH signaling pathway, linoleic acid metabolism, long term depression and melanogenesis were enriched in the HC group, whereas arginine and proline metabolism, citrate cycle TCA cycle, fatty acid metabolism, propanoate metabolism, and valine leucine and isoleucine degradation were significantly enriched in the DN group.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Functional enrichment analysis and GSEA analysis for DE-MRGs. <bold>(A)</bold> GO enrichment analysis of the DE-MRGs. <bold>(B)</bold> KEGG enrichment analysis shows the top 15 enriched signaling pathways of the DE-MRGs. <bold>(C, D)</bold> The results of GSEA displays the top 5 KEGG signaling pathways in HC and DN group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Identification of diagnostic feature biomarkers</title>
<p>Multiple machine learning algorithms were utilized to screen the diagnostic feature biomarkers in DN. A gene co-expression network was established according to weighted gene co-expression network analysis (WGCNA). The power of <italic>&#x3b2;</italic> = 6 (scale-free R<sup>2</sup> &gt; 0.85) was selected as the soft-thresholding parameter to construct a scale-free network, and the correlation coefficient of the module eigengenes and disease characteristics were calculated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). The results of the module trait showed the correlation of the module eigengenes and the disease characteristics. Of note, the module blue was positively correlated with DN, and was selected for the subsequent analysis (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). Based on the LASSO algorithm, 26 DE-MRGs were identified as diagnostic feature biomarkers for DN (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4C, D</bold>
</xref>). 16 DE-MRGs were identified as diagnostic biomarkers from the DE-MRGs using the SVM-RFE algorithm (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). Additionally, 11 diagnostic feature biomarkers were selected from the DE-MRGs using the RFE algorithm (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4F</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Identification of diagnostic feature biomarkers using multiple machine learning algorithm. <bold>(A)</bold> Analysis of the scale-free network for various soft-thresholding powers (<italic>&#x3b2;</italic>). <bold>(B)</bold> Heatmap shows the correlation of the module eigengenes and disease clinical characteristics. <bold>(C, D)</bold> Least absolute shrinkage and selection operator (LASSO) algorithm shows the optimal coefficient and minimal lambda of the DE-MRGs. <bold>(E)</bold> Support vector machine (SVM) algorithm shows the minimal RMSE of the DE-MRGs. <bold>(F)</bold> The random forest (RFE) algorithm shows the diagnostic feature biomarkers based on the DE-MRGs, with the importance more than 0.5.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Identification and validation of the diagnostic feature biomarkers</title>
<p>According to the four machine learning algorithms, 4 diagnostic feature biomarkers were identified (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). The expression of the 4 diagnostic feature biomarkers in the training cohort showed that <italic>ADI1</italic> and <italic>PTGS2</italic> were expressed higher in the HC group, however, the DN group showed a higher expression of <italic>DGKH</italic> and <italic>POLR2B</italic> (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). In validation cohort, the expression of <italic>ADI1</italic> and <italic>PTGS2</italic> were higher in the HC group, whereas the expression of <italic>DGKH</italic> and <italic>POLR2B</italic> were lower in the DN group compared to the HC group (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). The ROC curve of the <italic>ADI1</italic>, <italic>PTGS2</italic>, <italic>DGKH</italic>, and <italic>POLR2B</italic> revealed a satisfactory diagnostic value for the 4 diagnostic feature biomarkers in the training cohort with AUC was 0.954, 0.994, 0.993, and 0.926, respectively (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). The AUC of <italic>ADI1</italic>, <italic>PTGS2</italic>, <italic>DGKH</italic>, and <italic>POLR2B</italic> in the validation cohort was 0.893, 1, 1, and 0.996, respectively (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5E</bold>
</xref>). Overall, these above findings demonstrate a satisfactory diagnostic value of the 4 diagnostic feature biomarkers and could be applied to the clinical diagnosis of DN.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Identification and validation of the diagnostic biomarkers. <bold>(A)</bold> Venn diagram shows the intersection of diagnostic biomarkers based on the four machine learning algorithms. The expression of the 4 diagnostic biomarkers in training cohort <bold>(B, C)</bold> validation cohort. <bold>(D, E)</bold> ROC analysis shows the diagnostic effectiveness of the 4 diagnostic biomarkers in training cohort and validation cohort.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Immune infiltration landscape analysis</title>
<p>In addition to metabolic disorders, immune system disorders are another important aspect of diabetic nephropathy (<xref ref-type="bibr" rid="B13">13</xref>). To investigate the immune infiltration landscape of patients, CIBERSORT algorithm was performed and the fraction of 22-types immune cells were assessed (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6A</bold>
</xref>). The correlation analysis revealed a remarkable correlation in the 22-types immune cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6B</bold>
</xref>). T cells CD8 was positively correlated with T cells CD4 na&#xef;ve, T cells CD4 memory resting, and T cells CD4 + memory; B cells memory was positively correlated with B cells na&#xef;ve; neutrophils was negatively correlated with T cells CD4 + memory, B cells na&#xef;ve, B cells memory, and Monocytes; T cells CD4 memory resting was negatively correlated with macrophages M2. As shown in <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>, the violin diagram showed that the fraction of B cells na&#xef;ve, B cells memory, T cells CD8, T cells CD4 na&#xef;ve, T cells CD4 memory resting, Macrophages M0, and mast cells resting were significantly higher in the DN group than HC group. However, the HC group had a higher proportion of macrophages M2 and neutrophils.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Immune infiltration analysis in HC and DN group. <bold>(A)</bold> Bar plot shows the fraction of the 22-types immune cells in the HC and DN group. <bold>(B)</bold> Correlation analysis of the 22-types immune cells. <bold>(C)</bold> Violin diagram shows the fraction of 22-type immune cells in HC and DN group based on the CIBERSORT algorithm.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g006.tif"/>
</fig>
</sec>
<sec id="s3_6">
<title>Correlation analysis of diagnostic biomarkers and immune infiltration landscape</title>
<p>The correlation analysis of the diagnostic biomarkers and immune infiltration landscape was further investigated. <italic>POLR2B</italic> was positively correlated with B cells na&#xef;ve, B cells na&#xef;ve, mast cells resting, T cells CD4 memory resting, macrophages M0, T cells CD4 memory activated, T cells gamma delta, and T cells CD8, but negatively correlated with macrophages M2 and neutrophils (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). <italic>PTGS2</italic> was positively correlated with NK cells activated, but negatively Macrophages M0 (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). <italic>DGKH</italic> was positively correlated with B cells na&#xef;ve, Mast cells resting, B cells memory, T cells CD4 memory resting, Macrophages M0, but negatively correlated with Macrophages M2 and Neutrophils (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). In addition, <italic>ADI1</italic> was positively correlated with macrophages M2, neutrophils, dendritic cells activated, but negatively correlated with macrophages M1, B cells memory, T cells CD4 memory resting, T cells CD4 memory activated, T cells gamma delta, T cells CD8, NK cells activated, monocytes, T cells follicular helper, macrophages M0, T cells CD4 na&#xef;ve, and B cells na&#xef;ve (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>). Taken together, these results demonstrate that the diagnostic feature biomarkers are correlated with immune infiltration landscape, providing a fresh insight for the future research in DN.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Correlation analysis between the diagnostic biomarkers and 22-types immune cells. Lollipop diagram reveals the relationship of the 22-types immune cells and <bold>(A)</bold> POLR2B, <bold>(B)</bold> PTGS2, <bold>(C)</bold> DGKH, and <bold>(D)</bold> ADI1.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1026938-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The involvement of metabolic diseases in the development of DN has attracted increasing attention. In this study, we used a variety of bioinformatics algorithms to study the role of MRGs in the pathogenesis of DN. Four MRGs were identified as diagnostic characteristic biomarkers of DN, indicating the importance role of MRGs in the DN process.</p>
<p>We observed significantly reduced <italic>ADI1</italic> mRNA expression levels in DN patients. As one of the four genes associated with prognosis, <italic>ADI1</italic> has not been reported in DN. As a metabolism-related gene, <italic>ADI1</italic> has been reported to be associated with the production of methionine metabolites S-adenosine methionine (SAM) and methionine sulfoxide (<xref ref-type="bibr" rid="B14">14</xref>). Higher plasma levels of methionine metabolites, including SAM, have been reported in diabetic nephropathy patients than in diabetic patients without nephropathy, and are associated with higher morbidity and mortality in diabetic nephropathy patients (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). In addition, the depletion of <italic>ADI1</italic> can be caused by iron depletion (<xref ref-type="bibr" rid="B18">18</xref>). Whereas iron deficiency has been shown to be beneficial for coronary response, endothelial dysfunction, insulin secretion, insulin action, and metabolic control in type 2 diabetes mellitus (<xref ref-type="bibr" rid="B19">19</xref>). In contrast, ferroptosis caused by iron overload leads to tubular cell death in diabetic nephropathy (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). However, this does not explain the reduced rather than increased <italic>ADI1</italic> expression levels we found in DN patients. Our further data showed that <italic>ADI1</italic> expression level was positively correlated with M2 macrophages and neutrophils, and negatively correlated with B cells, CD4 T cells, and CD8+T cells, suggesting that <italic>ADI1</italic> was associated with inhibitory immunophenotype. Combined with the reduction in <italic>ADI1</italic> expression levels found above in DN patients, our data support the existence of reduced <italic>ADI1</italic> levels and increased immune system activation levels in DN patients. The involvement of the immune system as one of the important pathogenic causes of DN partially confirmed the significance of reduced <italic>ADI1</italic> level in DN patients.</p>
<p>
<italic>DGKH</italic> diacylglycerol kinase (DGK) is a member of the enzyme family. Members of this family are involved in regulating the intracellular concentrations of diacylglycerol and phosphatidic acid. Studies on <italic>DGKH</italic> mainly focus on bipolar disorder, unipolar depression and adult attention-deficit/hyperactivity disorder (ADHD), etc. (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). These results show that <italic>DGKH</italic> plays an important role in brain lipid metabolism. In addition, <italic>DGKH</italic> is associated with the formation of kidney stones by affecting calcium sensitive receptor (CasR) signaling and calcium metabolism in the body (<xref ref-type="bibr" rid="B24">24</xref>). Although there is no relevant study on <italic>DGKH</italic> in DN, it has been reported that there is a highly significant correlation between glomerular filtration rate, inflammation and lipid metabolism genes, supporting the possible role of abnormal lipid metabolism in the pathogenesis of DN (<xref ref-type="bibr" rid="B9">9</xref>). The role of <italic>DGKH</italic> in DN needs to be further confirmed.</p>
<p>As the second largest subunit encoding RNA polymerase II (Pol II), <italic>POLR2B</italic> catalyzes the transcription of DNA into mRNA, snRNA and microRNA precursors. This subunit and the largest subunit form opposite sides of the Pol II central cleft. Its alternative splicing results in multiple transcriptional variants (<xref ref-type="bibr" rid="B25">25</xref>). <italic>POLR2B</italic> has been reported to be associated with macular degeneration at home and abroad (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Because macular degeneration is closely related to diabetes, <italic>POLR2B</italic> may be involved in the process of diabetes. In addition, <italic>POLR2B</italic> is involved in the regulation of protein kinase, DNA-activated, catalytic subunit (PRKDC) and RNA polymerase II. The recruitment of Pol II to HBV Covalently closed circular DNA (cccDNA) assists in the phosphorylation of Pol II at Ser5 and Ser2, thereby promoting HBV transcription (<xref ref-type="bibr" rid="B28">28</xref>). Chronic hepatitis B virus infection as an independent predictor of renal outcome in patients with type 2 diabetes mellitus (<xref ref-type="bibr" rid="B29">29</xref>) also suggests an important role for <italic>POLR2B</italic> in DN.</p>
<p>Compared with <italic>POLR2B</italic>, <italic>PTGS2</italic> is convincingly involved in the development of DN. Immune dysfunction is one of the important factors of progressive nephropathy. It is traditionally believed that <italic>PTGS2</italic>, as an important mediator of inflammatory injury in diseases, produces prostaglandins (PGs) that are related to pathologic renal hemodynamics in diabetes and mediate renal injury caused by hemodynamic changes. (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). However, recent reports suggest that the role of <italic>PTGS2</italic> in the development of DN and other renal injuries is complex. The expression of <italic>PTGS2</italic> in macrophages prevents the development of diabetic nephropathy (<xref ref-type="bibr" rid="B32">32</xref>). Meanwhile, specific knockdown of <italic>PTGS2</italic> in podocytes exacerbates diabetic nephropathy (<xref ref-type="bibr" rid="B33">33</xref>). This is consistent with our observation of lower M2 macrophage expression levels and lower <italic>PTGS2</italic> mRNA expression levels in DN. Our results support the idea that the role of <italic>PTGS2</italic> in renal injury may depend on the source of <italic>PTGS2</italic>, the mechanism of renal injury, and the expression and subtype of PGE 2 receptors (<xref ref-type="bibr" rid="B32">32</xref>). Further data showed <italic>PTGS2</italic> expression level was positively correlated with expressions of M2 macrophages, NK cells and gamma delta T cells. Meanwhile, it was negatively correlated with B cell, CD4 T cell, and CD8+ T cell expressions. Similar to ADI1, the above results also suggest that PTGS2 is associated with a suppressive immunophenotype. Combined with the decreased PTGS2 expression level we found in the above-mentioned DN patients; it is partially confirmed that the decreased <italic>PTGS2</italic> levels in DN patients may be related to the enhanced activation of the immune system.</p>
<p>The correlation between immune cells and diagnostic biomarkers was preliminarily discussed. We observed lower M2 macrophage levels in DN patients as a result of immune infiltration. In contrast to the pro-inflammatory and pro-DN effects of M1 (<xref ref-type="bibr" rid="B34">34</xref>), polarization of renal M1 macrophages to M2 phenotype can ameliorate experimental diabetic kidney injury by inhibiting renal M1 macrophages (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). This is associated with a decrease in proinflammatory cytokines/chemokines, extracellular matrix/profibrotic proteins, and improved renal function and histology (<xref ref-type="bibr" rid="B36">36</xref>). In addition, PGE 2 production by <italic>PTGS2</italic> is important for macrophage polarization to the M2 phenotype (<xref ref-type="bibr" rid="B37">37</xref>). Above, we observed that lower <italic>PTGS2</italic> in DN may also be involved in the regulation of immune infiltration. In view of the important ameliorative effect of Pentraxin-3 and other drugs on the polarization of macrophages into M2 phenotype in DN, focusing on macrophage phenotype may play a more important role in DN treatment in the future (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>In conclusion, the present study employed a variety of bioinformatic algorithms to investigate the role of MRGs in the pathogenesis of DN, and identified 4 MRGs as diagnostic biomarkers for DN. In addition, the correlation of immune cells with diagnostic biomarkers was initially discussed. By combining studies on the relationship between metabolism and immune microenvironment, this study provides new perspectives and insights for the future treatment of DN patients.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>JZ and HZ conceived and designed the study. QL contributed the data collection and data analysis. LF conceived the original ideas and composed this manuscript. JH contributed the table and figures of this manuscript. JH and HZ contributed equally to this article and all authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valencia</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Florez</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>How to prevent the microvascular complications of type 2 diabetes beyond glucose control</article-title>. <source>BMJ</source> (<year>2017</year>) <volume>356</volume>:<elocation-id>i6505</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.i6505</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burrows</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Hora</surname> <given-names>I</given-names>
</name>
<name>
<surname>Geiss</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Gregg</surname> <given-names>EW</given-names>
</name>
<name>
<surname>Albright</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes - united states and Puerto Rico 2000-2014</article-title>. <source>MMWR Morb Mortal Wkly Rep</source> (<year>2017</year>) <volume>66</volume>(<issue>43</issue>):<page-range>1165&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.15585/mmwr.mm6643a2</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Long</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Trends in chronic kidney disease in China</article-title>. <source>N Engl J Med</source> (<year>2016</year>) <volume>375</volume>(<issue>9</issue>):<page-range>905&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMc1602469</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stenvinkel</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease</article-title>. <source>J Intern Med</source> (<year>2010</year>) <volume>268</volume>(<issue>5</issue>):<page-range>456&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2796.2010.02269.x</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gui</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhai</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Mechanistic insight and management of diabetic nephropathy: Recent progress and future perspective</article-title>. <source>J Diabetes Res</source> (<year>2017</year>) <volume>2017</volume>:<elocation-id>1839809</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/1839809</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opazo-Rios</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mas</surname> <given-names>S</given-names>
</name>
<name>
<surname>Marin-Royo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Mezzano</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gomez-Guerrero</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moreno</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>21</volume>(<issue>7</issue>)<fpage>:2632</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21072632</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tambyraja</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>Drugs in feto maternal medicine</article-title>. <source>Ann Acad Med Singap</source> (<year>1987</year>) <volume>16</volume>(<issue>2</issue>):<page-range>281&#x2013;5</page-range>.</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falkevall</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mehlem</surname> <given-names>A</given-names>
</name>
<name>
<surname>Palombo</surname> <given-names>I</given-names>
</name>
<name>
<surname>Heller Sahlgren</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ebarasi</surname> <given-names>L</given-names>
</name>
<name>
<surname>He</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Reducing VEGF-b signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease</article-title>. <source>Cell Metab</source> (<year>2017</year>) <volume>25</volume>(<issue>3</issue>):<page-range>713&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2017.01.004</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herman-Edelstein</surname> <given-names>M</given-names>
</name>
<name>
<surname>Scherzer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tobar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Levi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gafter</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy</article-title>. <source>J Lipid Res</source> (<year>2014</year>) <volume>55</volume>(<issue>3</issue>):<page-range>561&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1194/jlr.P040501</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaziri</surname> <given-names>ND</given-names>
</name>
</person-group>. <article-title>Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences</article-title>. <source>Kidney Int</source> (<year>2016</year>) <volume>90</volume>(<issue>1</issue>):<fpage>41</fpage>&#x2013;<lpage>52</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.kint.2016.02.026</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>TS</given-names>
</name>
</person-group>. <article-title>Update of pathophysiology and management of diabetic kidney disease</article-title>. <source>J Formos Med Assoc</source> (<year>2018</year>) <volume>117</volume>(<issue>8</issue>):<page-range>662&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jfma.2018.02.007</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>QY</given-names>
</name>
</person-group>. <article-title>clusterProfiler: an r package for comparing biological themes among gene clusters</article-title>. <source>OMICS</source> (<year>2012</year>) <volume>16</volume>(<issue>5</issue>):<page-range>284&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname> <given-names>J</given-names>
</name>
<name>
<surname>Makino</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Innate immunity in diabetes and diabetic nephropathy</article-title>. <source>Nat Rev Nephrol</source> (<year>2016</year>) <volume>12</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrneph.2015.175</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chou</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Shiu</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Shiao</surname> <given-names>MS</given-names>
</name>
<etal/>
</person-group>. <article-title>ADI1, a methionine salvage pathway enzyme, is required for drosophila fecundity</article-title>. <source>J BioMed Sci</source> (<year>2014</year>) <volume>21</volume>:<elocation-id>64</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12929-014-0064-4</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poirier</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Fink</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Wise</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Randolph</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Delongchamp</surname> <given-names>RR</given-names>
</name>
<etal/>
</person-group>. <article-title>Blood s-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy</article-title>. <source>Metabolism</source> (<year>2001</year>) <volume>50</volume>(<issue>9</issue>):<page-range>1014&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/meta.2001.25655</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrmann</surname> <given-names>W</given-names>
</name>
<name>
<surname>Schorr</surname> <given-names>H</given-names>
</name>
<name>
<surname>Obeid</surname> <given-names>R</given-names>
</name>
<name>
<surname>Makowski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fowler</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kuhlmann</surname> <given-names>MK</given-names>
</name>
</person-group>. <article-title>Disturbed homocysteine and methionine cycle intermediates s-adenosylhomocysteine and s-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes</article-title>. <source>Clin Chem</source> (<year>2005</year>) <volume>51</volume>(<issue>5</issue>):<page-range>891&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1373/clinchem.2004.044453</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: application to studies of diabetic nephropathy</article-title>. <source>Talanta</source> (<year>2009</year>) <volume>77</volume>(<issue>4</issue>):<page-range>1279&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.talanta.2008.08.031</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Lane</surname> <given-names>DJR</given-names>
</name>
<name>
<surname>Siafakas</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Sutak</surname> <given-names>R</given-names>
</name>
<name>
<surname>Paluncic</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>MLH</given-names>
</name>
<etal/>
</person-group>. <article-title>Acireductone dioxygenase 1 (ADI1) is regulated by cellular iron by a mechanism involving the iron chaperone, PCBP1, with PCBP2 acting as a potential co-chaperone</article-title>. <source>Biochim Biophys Acta Mol Basis Dis</source> (<year>2020</year>) <volume>1866</volume>(<issue>10</issue>):<elocation-id>165844</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2020.165844</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Real</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Lopez-Bermejo</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ricart</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Cross-talk between iron metabolism and diabetes</article-title>. <source>Diabetes</source> (<year>2002</year>) <volume>51</volume>(<issue>8</issue>):<page-range>2348&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/diabetes.51.8.2348</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldberg</surname> <given-names>IJ</given-names>
</name>
<name>
<surname>Handley</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Vanni</surname> <given-names>T</given-names>
</name>
<name>
<surname>Paterniti</surname> <given-names>JR</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Cornicelli</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold technique</article-title>. <source>Biochim Biophys Acta</source> (<year>1988</year>) <volume>959</volume>(<issue>3</issue>):<page-range>220&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0005-2760(88)90194-4</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Quan</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Ferroptosis involves in renal tubular cell death in diabetic nephropathy</article-title>. <source>Eur J Pharmacol</source> (<year>2020</year>) <volume>888</volume>:<elocation-id>173574</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2020.173574</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takata</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kawasaki</surname> <given-names>H</given-names>
</name>
<name>
<surname>Iwayama</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>K</given-names>
</name>
<name>
<surname>Gotoh</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mitsuyasu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Nominal association between a polymorphism in DGKH and bipolar disorder detected in a meta-analysis of East Asian case-control samples</article-title>. <source>Psychiatry Clin Neurosci</source> (<year>2011</year>) <volume>65</volume>(<issue>3</issue>):<page-range>280&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1440-1819.2011.02193.x</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weissflog</surname> <given-names>L</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bossert</surname> <given-names>N</given-names>
</name>
<name>
<surname>Freudenberg</surname> <given-names>F</given-names>
</name>
<name>
<surname>Kittel-Schneider</surname> <given-names>S</given-names>
</name>
<name>
<surname>Reif</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Expressional profile of the diacylglycerol kinase eta gene DGKH</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source> (<year>2017</year>) <volume>267</volume>(<issue>5</issue>):<page-range>445&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00406-016-0695-4</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howles</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Wiberg</surname> <given-names>A</given-names>
</name>
<name>
<surname>Goldsworthy</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bayliss</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Gluck</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetic variants of calcium and vitamin d metabolism in kidney stone disease</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>(<issue>1</issue>):<fpage>5175</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-13145-x</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langelier</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Baali</surname> <given-names>D</given-names>
</name>
<name>
<surname>Trinh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Greenblatt</surname> <given-names>J</given-names>
</name>
<name>
<surname>Archambault</surname> <given-names>J</given-names>
</name>
<name>
<surname>Coulombe</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>The highly conserved glutamic acid 791 of Rpb2 is involved in the binding of NTP and Mg(B) in the active center of human RNA polymerase II</article-title>. <source>Nucleic Acids Res</source> (<year>2005</year>) <volume>33</volume>(<issue>8</issue>):<page-range>2629&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gki570</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arakawa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ashikawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hosono</surname> <given-names>N</given-names>
</name>
<name>
<surname>Aoi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yasuda</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population</article-title>. <source>Nat Genet</source> (<year>2011</year>) <volume>43</volume>(<issue>10</issue>):<page-range>1001&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng.938</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>RAD51 gene is associated with advanced age-related macular degeneration in Chinese population</article-title>. <source>Clin Biochem</source> (<year>2013</year>) <volume>46</volume>(<issue>16-17</issue>):<page-range>1689&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clinbiochem.2013.07.002</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>PRKDC promotes hepatitis b virus transcription through enhancing the binding of RNA pol II to cccDNA</article-title>. <source>Cell Death Dis</source> (<year>2022</year>) <volume>13</volume>(<issue>4</issue>):<fpage>404</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-022-04852-3</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>VW</given-names>
</name>
<name>
<surname>So</surname> <given-names>WY</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>CS</given-names>
</name>
<etal/>
</person-group>. <article-title>Chronic hepatitis b viral infection independently predicts renal outcome in type 2 diabetic patients</article-title>. <source>Diabetologia</source> (<year>2006</year>) <volume>49</volume>(<issue>8</issue>):<page-range>1777&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00125-006-0294-4</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komers</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lindsley</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Oyama</surname> <given-names>TT</given-names>
</name>
<name>
<surname>Schutzer</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Reed</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Mader</surname> <given-names>SL</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes</article-title>. <source>J Clin Invest</source> (<year>2001</year>) <volume>107</volume>(<issue>7</issue>):<page-range>889&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI10228</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zatz</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fujihara</surname> <given-names>CK</given-names>
</name>
</person-group>. <article-title>Cyclooxygenase-2 inhibitors: will they help us prevent diabetic nephropathy</article-title>? <source>Kidney Int</source> (<year>2002</year>) <volume>62</volume>(<issue>3</issue>):<page-range>1091&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00542.x</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage cyclooxygenase-2 protects against development of diabetic nephropathy</article-title>. <source>Diabetes</source> (<year>2017</year>) <volume>66</volume>(<issue>2</issue>):<fpage>494</fpage>&#x2013;<lpage>504</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db16-0773</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sha</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Eisner</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sparks</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Buckley</surname> <given-names>AF</given-names>
</name>
<etal/>
</person-group>. <article-title>Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease</article-title>. <source>Am J Physiol Renal Physiol</source> (<year>2017</year>) <volume>313</volume>(<issue>2</issue>):<page-range>F430&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajprenal.00614.2016</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devaraj</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tobias</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kasinath</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Ramsamooj</surname> <given-names>R</given-names>
</name>
<name>
<surname>Afify</surname> <given-names>A</given-names>
</name>
<name>
<surname>Jialal</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2011</year>) <volume>31</volume>(<issue>8</issue>):<page-range>1796&#x2013;804</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.228924</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xian</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Pentraxin-3 attenuates renal damage in diabetic nephropathy by promoting M2 macrophage differentiation</article-title>. <source>Inflammation</source> (<year>2015</year>) <volume>38</volume>(<issue>5</issue>):<page-range>1739&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-015-0151-z</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ndisang</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Jadhav</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis</article-title>. <source>Endocrinology</source> (<year>2014</year>) <volume>155</volume>(<issue>1</issue>):<page-range>215&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2013-1050</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takayama</surname> <given-names>K</given-names>
</name>
<name>
<surname>Garcia-Cardena</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sukhova</surname> <given-names>GK</given-names>
</name>
<name>
<surname>Comander</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gimbrone</surname> <given-names>MA</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Libby</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor</article-title>. <source>J Biol Chem</source> (<year>2002</year>) <volume>277</volume>(<issue>46</issue>):<page-range>44147&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M204810200</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>